Nucleocapsids

The structure of the proteins of Camp Hill virus

Sunil Thomas

published 22 Oct 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in North Carolina from December 2020 – February 2022

Elyse M. Miller, Ross M. Boyce, Aaron M. Kipp, L Kristin Newby, Christopher W. Woods, Caitlin A. Cassidy, Annika K. Gunderson, C Suzanne Lea, Coralei E. Neighbors, Bonnie E. Shook-Sa, Richard Sloane, Anne P. Starling, David Wambui, Douglas Wixted, Aaron Fleischauer, Allison E. Aiello

published 08 Oct 2025

Loading metrics information...

Metrics unavailable. Please check back later.

In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19

Imra Aqeel, Abdul Majid, Tahani Jaser Alahmadi, Areej Althubaity

published 25 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Elizabeth S. Munroe, Greg A. Grandits, Robert C. Hyzy, Hallie C. Prescott, Thomas W. Barrett, Robin L. Dewar, Nicole Engen, Anna L. Goodman, Timothy J. Hatlen, Helene Highbarger, Thomas L. Holland, Gareth Hughes, Tomas O. Jensen, Muhammad A. Khan, Ioannis Kalomenidis, Nayon Kang, Sylvain Laverdure, Prasad Manian, Vidya Menon, Ravi Patel, Srikanth Ramachandruni, Tauseef Rehman, Kathryn Shaw-Saliba, Birgit Thorup Røge, David M. Vock, Amy C. Weintrob, Barnaby E. Young, Anne P. Frosch, for the STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups

published 18 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets

Abdelhadi Djaïleb, Megan-Faye Parker, Étienne Lavallée, Matthew Stuible, Yves Durocher, Mathieu Thériault, Kim Santerre, Caroline Gilbert, Denis Boudreau, Mariana Baz, Jean-Francois Masson, Marc-André Langlois, Sylvie Trottier, Daniela Quaglia, Joelle N. Pelletier

published 16 Dec 2024

Loading metrics information...

Metrics unavailable. Please check back later.

The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study

Archana Koirala, Jocelynne McRae, Philip N. Britton, Marnie Downes, Shayal A. Prasad, Suellen Nicholson, Noni E. Winkler, Matthew V. N. O’Sullivan, Fatima Gondalwala, Cecile Castellano, Emma Carey, Alexandra Hendry, Nigel Crawford, Ushma Wadia, Peter Richmond, Helen S. Marshall, Julia E. Clark, Joshua R. Francis, Jeremy Carr, Adam Bartlett, Brendan McMullan, Justin Skowno, Donald Hannah, Andrew Davidson, Britta S. von Ungern-Sternberg, Paul Lee-Archer, Laura .L Burgoyne, Edith B. Waugh, John B. Carlin, Zin Naing, Nicole Kerly, Alissa McMinn, Guillian Hunter, Christine Heath, Natascha D’Angelo, Carolyn Finucane, Laura A. Francis, Sonia Dougherty, William Rawlinson, Theo Karapanagiotidis, Natalie Cain, Rianne Brizuela, Christopher C. Blyth, Nicholas Wood, Kristine Macartney

published 18 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022

Penelope Gray, Tiina Eriksson, Lovisa Skoglund, Camilla Lagheden, Ceke Hellström, Elisa Pin, Anna Suomenrinne-Nordvik, Ville N. Pimenoff, Peter Nilsson, Joakim Dillner, Matti Lehtinen

published 11 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Assessment of positive selection across SARS-CoV-2 variants via maximum likelihood

Carly Middleton, Laura Kubatko

published 14 Sep 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Candidate historical events for the emergence of Human Coronavirus OC43: A critical reassessment of the molecular evidence

Brandon Shaw, Derek Gatherer

published 08 May 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Comparison of new and emerging SARS-CoV-2 variant transmissibility through active contact testing. A comparative cross-sectional household seroprevalence study

Katherine M. Gaskell, Natalie El Kheir, Mariyam Mirfendesky, Tommy Rampling, Michael Marks, Catherine F. Houlihan, Norbert Lemonge, Hannah Bristowe, Suhail Aslam, Demetra Kyprianou, Eleni Nastouli, David Goldblatt, Katherine Fielding, David A. J. Moore, CONTACT team (field team)

published 24 Apr 2023

Loading metrics information...

Metrics unavailable. Please check back later.

A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study

Emily J. Doucette, Joslyn Gray, Kevin Fonseca, Carmen Charlton, Jamil N. Kanji, Graham Tipples, Susan Kuhn, Jessica Dunn, Payton Sayers, Nicola Symonds, Guosong Wu, Stephen B. Freedman, James D. Kellner

published 06 Apr 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics

Steven Odongo, Hedmon Okella, Christian Ndekezi, Moses Okee, Monica Namayanja, Brian Mujuni, Yann G. J. Sterckx, Dennison Kizito, Magdalena Radwanska, Stefan Magez, Kokas Ikwap, Frank Nobert Mwiine, Julius Julian Lutwama, Charles Ibingira

published 22 Dec 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19

Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, Bastian Engel, Louisa Ruhl, Isabell Pink, Nele Thomas, Joerg Martens, Marius M. Hoeper, Rainer Blasczyk, Heiner Wedemeyer, Elmar Jaeckel, Yang Li, Christine S. Falk, Britta Eiz-Vesper, Richard Taubert

published 02 Nov 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Nucleocapsids

The structure of the proteins of Camp Hill virus

Incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in North Carolina from December 2020 – February 2022

In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets

The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study

Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022

Assessment of positive selection across SARS-CoV-2 variants via maximum likelihood

Candidate historical events for the emergence of Human Coronavirus OC43: A critical reassessment of the molecular evidence

Comparison of new and emerging SARS-CoV-2 variant transmissibility through active contact testing. A comparative cross-sectional household seroprevalence study

A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study

Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics

Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19

Nucleocapsids

Connect with Us